CV Sciences (CVSI) Net Cash Flow (2011 - 2026)
CV Sciences' (CVSI) quarterly Net Cash Flow came in at $30000.0 in Q1 2026, down 91.64% year-on-year from $359000.0 in Q1 2025, and up 151.72% quarter-over-quarter from -$58000.0 in Q4 2025.
CV Sciences (CVSI) Net Cash Flow (2011 - 2026) Analysis & Trends
CV Sciences has disclosed Net Cash Flow across 16 years of filings, most recently posting $30000.0 for Q1 2026.
- Net Cash Flow for Q1 2026 came in at $30000.0, down 91.64% year-over-year; the trailing twelve-month figure through Mar 2026 was -$508000.0 (down 425.64% YoY), and the FY2025 annual result was -$179000.0, up 79.11% from the prior year.
- Net Cash Flow came in at $30000.0 for Q1 2026 at CV Sciences, up from -$58000.0 in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $1.1 million in Q1 2022 to a low of -$1.3 million in Q2 2022.
- The 5-year median for Net Cash Flow is -$47000.0 (2023), against an average of -$62588.2.
- Peak annual rise in Net Cash Flow reached 1168.09% in 2024, while the deepest fall reached 734.95% in 2024.
- CV Sciences' Net Cash Flow stood at -$528000.0 in 2022, then jumped by 38.26% to -$326000.0 in 2023, then sank by 59.82% to -$521000.0 in 2024, then surged by 88.87% to -$58000.0 in 2025, then jumped by 151.72% to $30000.0 in 2026.
- The last three Net Cash Flow figures came in at $30000.0 (Q1 2026), -$58000.0 (Q4 2025), and -$551000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 202.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -526.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -277.40 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -446.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -112.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -768.22 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -3.97 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 139.49 Mn |
| 10 | CV Sciences | - | - | 1.56 Mn | 30,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30,000.00 |
| Mar 31, 2026 | 30,000.00 |
| Dec 31, 2025 | -58,000.00 |
| Dec 31, 2025 | -58,000.00 |
| Sep 30, 2025 | -551,000.00 |
| Sep 30, 2025 | -551,000.00 |
| Jun 30, 2025 | 71,000.00 |
| Jun 30, 2025 | 71,000.00 |
| Mar 31, 2025 | 359,000.00 |
| Mar 31, 2025 | 359,000.00 |
| Dec 31, 2024 | -521,000.00 |
| Dec 31, 2024 | -521,000.00 |
| Sep 30, 2024 | 502,000.00 |
| Sep 30, 2024 | 502,000.00 |
| Jun 30, 2024 | -184,000.00 |
| Jun 30, 2024 | -184,000.00 |
| Mar 31, 2024 | -654,000.00 |
| Mar 31, 2024 | -654,000.00 |
| Dec 31, 2023 | -326,000.00 |
| Dec 31, 2023 | -326,000.00 |